Company: PSTV
Filing Date: 2025-07-21
Form Type: DEF 14A
Source: 0001140361-25-026611
Chunk: 16

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-07-21
Form: DEF 14A
Chunk 16
---
 are not aware of any items, other than those referred to in the accompanying Notice, which may properly come before the meeting or other matters incident to the conduct of the meeting. As to any other item or proposal that may properly come before the meeting, it is intended that proxies will be voted in the discretion of the proxy holders. How can I view or request copies of the Company’s corporate documents and SEC filings, including the Annual Report? The Company’s website contains, among other corporate governance documents, the Company’s Corporate Governance Guidelines and Codes of Business Conduct & Ethics. To view these documents, go to www.plustherapeutics.com, click “For Investors” then “Governance” and then “Corporate Governance Materials.” To view the Company’s committee charters, go to www.plustherapeutics.com, click “For Investors” then “Governance” and then “Board Committees.” To view the Company’s SEC filings, including Forms 3, 4 and 5 filed by the Company’s directors and executive officers, go to www.plustherapeutics.com, click on “For Investors” then “Reports & Filings.” The 2024 Annual Report includes our consolidated financial statements for the year ended December 31, 2024. We have furnished the 2024 Annual Report to all stockholders. 8

TABLE OF CONTENTS

CORPORATE GOVERNANCE Director Candidates The names of the members of the Board and Plus’s director nominees, their respective ages, their positions with Plus and other biographical information as of June 18, 2025, are set forth below. Except for Marc H. Hedrick, M.D., our Chief Executive Officer, President and a director, there are no other family relationships among any of our directors or executive officers.

| Name                      |     | Director 
    Since |     | Chair  
 of the 
 Board  |     | Age |     | Position                                        |     | Audit     
 Committee |     | Compensation 
 Committee    |     | Nominating 
 and        
 Corporate  
 Governance 
 Committee  |
| Howard Clowes             |     |     2020 |     |        |     |  71 |     | Director                                        |     | •         |     | •            |     | •          |
| An van Es-Johansson, M.D. |     |     2020 |     |        |     |  65 |     | Director                                        |     | •         |     |              |     | •          |
| Richard